Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by CapitalJon Nov 30, 2016 4:16pm
426 Views
Post# 25536361

Globe and Mail Article

Globe and Mail ArticleMarijuana producer jumps 356% as Canadas investor pot frenzy intensifies Jen Skerritt and Eric Lam Bloomberg News Published Wednesday, Nov. 30, 2016 1:19PM EST Last updated Wednesday, Nov. 30, 2016 1:19PM EST The frenzy surrounding Canadian marijuana stocks, fueled by the countrys march toward legalization, intensified Tuesday after shares of one producer rose as much as fivefold in Toronto. ICC International Cannabis Corp. debuted on the TSX Venture Exchange and closed 356 per cent higher at $1.14. The Uruguayan company is one of several marijuana companies to post spectacular gains in Canadian trading this year. The federal government plans to legalize recreational use in 2017, and the countrys Task Force on Marijuana Legalization and Regulation is due to deliver a report on the subject to the government on Wednesday, although its findings may not be known publicly until next year. If legalization occurs along expected timelines, there will be about 3.8 million legal recreational users of marijuana across Canada by 2021 and the potential for $6-billion of sales, Canaccord Genuity analysts Matt Bottomley and Neil Maruoka said Monday in a note. The amount of capital flowing into publicly marijuana companies listed in Canada is causing wild fluctuations in share prices, according to PI Financial analyst Jason Zandberg. Theres a sea change in attitudes towards the burgeoning marijuana market, he said, and investors are looking to Canada because more difficult to invest in U.S. cannabis companies as theyre only legal in certain states. For us, this is the most interesting place to be trading, ICC Chief Executive Officer Guillermo Delmonte said in an interview in Bloombergs Toronto office. Canada is the market that is more familiarized and has more background about cannabis companies. Despite its surging stock price, ICC remains a small-cap, with a market valuation of $132.4-million. But some of its peers have grown considerably in size. Canopy Growth Corp., for example, a Canadian medical-marijuana producer with just $18.1-million of revenue in the year through September, has jumped 277 per cent in 2016 for a market capitalization of $1.3-billion. Aphria Inc. and Aurora Cannabis Inc., two other Canadian suppliers, are up 280 percent and 349 percent respectively for the year for market values of $478.8-million and $670.6-million. ICC surged as much as 14 per cent Wednesday and rose 3.5 per cent to $1.18 at 10:54 a.m. in Toronto. Aurora gained 5.7 per cent, while Canopy Growth added 0.4 per cent and Aphria climbed 1.4 per cent. The task forces report will be released once ministers have had a chance to review the recommendations, Radey Barrack, spokesman for Bill Blair, a lawmaker and parliamentary secretary to the Minister of Justice and Attorney General of Canada, said last week. The government may hold off on releasing details from the report until 2017 and it could be negative for existing marijuana distributors if it suggests a delayed timeline on sales, Mr. Zandberg said. The expectations are so high in the sector, he said in a telephone interview from Vancouver. Its hard to think of what could be in a report that would actually be an upside surprise given how high the expectations are right now. ICC is focusing for now on growth in South America, particularly in Argentina and Brazil, and in Europe, Delmonte said. It doesnt have plans to enter the Canadian market. The company expects to get the green light from the Uruguayan government to distribute recreational pot to pharmacies by the end of the year, and is readying a second plant to produce hemp and medicinal extracts around March or April of 2017, he said.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse